发明授权
![Substituted pyrido [2,3-d] pyrimidinone compounds](/docs/US/2010-12-28/US07858631B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted pyrido [2,3-d] pyrimidinone compounds
- 专利标题（中）： 取代的吡啶并[2,3-d]嘧啶酮化合物
-
申请号： US10515434申请日： 2003-05-23
-
公开(公告)号： US07858631B2公开(公告)日： 2010-12-28
- 发明人: Rustum S. Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Bryan Chang
- 申请人： Rustum S. Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Bryan Chang
- 申请人地址： US CA Emeryville
- 专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人地址： US CA Emeryville
- 代理商 Vinit Katherdekar; Michael G. Smith
- 国际申请： PCT/US03/16442 WO 20030523
- 国际公布： WO03/099878 WO 20031204
- 主分类号： A61K31/519
- IPC分类号： A61K31/519
![Substituted pyrido [2,3-d] pyrimidinone compounds](/abs-image/US/2010/12/28/US07858631B2/abs.jpg.150x150.jpg)
摘要：
A variety of low molecular weight, guanidino-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases. The compounds have the structure of Formulas (IA), (IB), or (IC): where the values of the variable are defined herein.
公开/授权文献
- US20060235019A1 Substituted quinazolinone compounds 公开/授权日：2006-10-19
信息查询
IPC分类:
